| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/01/1998 | CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 10/01/1998 | CA2283631A1 Secreted proteins and polynucleotides encoding them |
| 10/01/1998 | CA2283230A1 Method of making arylamino triazolopyridines |
| 10/01/1998 | CA2232461A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/30/1998 | EP0867513A2 Interleukin-1 beta converting enzyme apoptosis protease-10 |
| 09/30/1998 | EP0867509A2 Tumor necrosis related receptor, TR5 |
| 09/30/1998 | EP0867436A1 N-aryl-piperidine derivatives and their use as 5-HT1B receptor ligands |
| 09/30/1998 | EP0866865A1 Chimeric oligomers having an rna-cleavage activity |
| 09/30/1998 | EP0866790A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 09/30/1998 | EP0866692A1 Use of bicyclic mono- or diketone derivatives, resulting compounds, and use thereof as a drug for treating inflammation, migraine and shock |
| 09/30/1998 | EP0866691A1 Sublingual and buccal administration of selegiline |
| 09/30/1998 | EP0866656A1 Inhibition of tumor necrosis factor alpha |
| 09/30/1998 | CN1194583A Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignancies |
| 09/30/1998 | CN1194155A Pile curing suppository ointment and its preparing method |
| 09/30/1998 | CN1040000C Process for preparing derivatives substituted in position 15 of 20, 21-dinoreburnamenine |
| 09/30/1998 | CN1039998C Substituted cycloalkylacetamides and its preparation, medicine and use |
| 09/30/1998 | CN1039997C Cyanoquanidines and its salt and medicinal composition containing them |
| 09/29/1998 | US5814654 Treatment of hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia, cerebro-ischemic disorders, cell proliferation, endothelial cell injury |
| 09/29/1998 | US5814630 Quinazoline compounds |
| 09/29/1998 | US5814623 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides |
| 09/29/1998 | US5814622 Compound useful as trypsin like serine protease as thrombin inhibitors |
| 09/29/1998 | US5814620 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 09/29/1998 | US5814464 Nucleic acids encoding TIE-2 ligand-2 |
| 09/29/1998 | US5814301 Contrast agents for medical diagnosis of cardiovascular disorders |
| 09/29/1998 | CA2101775C Method of reducing elevated blood sugar levels in humans |
| 09/29/1998 | CA2043033C Use of baclofen to obtain medication for the treatment of angina |
| 09/27/1998 | CA2231055A1 Interleukin-1 beta converting enzyme like apoptosis protease-10 |
| 09/24/1998 | WO1998041639A1 Serine/threonine protein kinase |
| 09/24/1998 | WO1998041629A2 Death domain containing receptor 5 |
| 09/24/1998 | WO1998041562A1 Non-antigenic branched polymer conjugates |
| 09/24/1998 | WO1998041527A1 Pyrroloazepine compounds |
| 09/24/1998 | WO1998041506A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 09/24/1998 | WO1998041242A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 09/24/1998 | WO1998041232A2 Compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | WO1998041214A1 Remedies for ischemic reflow disturbances |
| 09/24/1998 | WO1998041201A1 Therapeutic compositions |
| 09/24/1998 | WO1998041200A1 Therapeutic compositions |
| 09/24/1998 | WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 09/24/1998 | DE19711795A1 Use of cyclosporin as immuno-modulator to treat myocardial infarction and its after-effects |
| 09/24/1998 | CA2644454A1 Death domain containing receptor 5 |
| 09/24/1998 | CA2284035A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 09/24/1998 | CA2283688A1 Serine/threonine protein kinase |
| 09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
| 09/24/1998 | CA2277179A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 09/24/1998 | CA2254875A1 Pyrroloazepine compounds |
| 09/23/1998 | EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 09/23/1998 | EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis |
| 09/23/1998 | EP0865428A1 Vitamin d analogues |
| 09/23/1998 | EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 09/23/1998 | EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 09/23/1998 | EP0865419A1 Indane dimer compounds and their pharmaceutical use |
| 09/23/1998 | EP0865294A1 Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| 09/23/1998 | EP0865291A1 Localized intravascular delivery of tfpi for inhibition of restenosis in recanalized blood vessels |
| 09/23/1998 | EP0700383B1 Novel 1-phenylalkanone 5-ht 4? receptor ligands |
| 09/23/1998 | EP0674637B1 Quinuclidine derivatives as squalene synthase inhibitors |
| 09/23/1998 | CN1193980A G-protein receptor HTNAD 29 |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193974A £1,2,4| triazolo £4,3-1| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193973A £1,2,4| triazolo £4,3-a| quinoxalinone derivatives, their preparation and use |
| 09/23/1998 | CN1193972A Heterocyclic compounds for treating myocardial ischaemia |
| 09/23/1998 | CN1193965A 10-acyloxy-10,11-dihydrodibenz/b, f/azepine-5-carboxamides useful for treating nervous system disorders |
| 09/23/1998 | CN1193913A Compounds and pharmaceutical compositions containing them |
| 09/23/1998 | CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 09/23/1998 | CN1193532A Pear hypotensor capsules and preparation thereof |
| 09/23/1998 | CN1039908C Tricyclic diazepine vasopressin antagonists |
| 09/22/1998 | USRE35903 Slow-release preparation of diltiazem, and a medicine provided thereby |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811549 Process of preparing imidazole compounds |
| 09/22/1998 | US5811548 Tri-and tetracyclic compounds |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811457 Therapeutical method for treating chronic arteriosclerosis obliterans |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811448 Pharmaceuticals useful for the treatment of cardiac arrhythmias |
| 09/22/1998 | US5811445 Angiotensin ii inhibitors |
| 09/22/1998 | US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds |
| 09/22/1998 | US5811437 Treating cardiovascular disorder, gastrointestinal disorder, nervous system disorder related to reduced endothelial nitric oxide production |
| 09/22/1998 | US5811429 Bicyclic heterocyclic compounds |
| 09/22/1998 | US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 09/22/1998 | US5811415 Lipophilic benzothiophenes |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
| 09/22/1998 | US5811389 Inhibiting platelet aggregation; blood disorders |
| 09/22/1998 | CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040408A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | WO1998040386A1 Dioxino derivatives and their use as therapeutic agents |
| 09/17/1998 | WO1998040384A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040344A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 09/17/1998 | WO1998040087A2 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION |
| 09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
| 09/17/1998 | WO1998028282A3 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/17/1998 | WO1998023244A3 Intracoronary stents containing quinazolinone derivatives |
| 09/17/1998 | DE19709877A1 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate 1,5-dihydro-pyrazolo [3,4-d] -pyrimidinone derivatives |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2283746A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 09/17/1998 | CA2283580A1 Use of human .alpha.1-acid glycoprotein for producing a pharmaceutical preparation |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283211A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives |